PRESS RELEASE published on 01/17/2024 at 08:00, 1 year 10 months ago Revolutionizing Drug Development: Novigenix Unveils AI-Powered RNA Analysis for Immune Response Profiling Novigenix, a leader in AI healthcare solutions, is launching LITOSeek™, a revolutionary innovation that utilizes advanced AI and RNA analysis to reshape cancer care and expedite drug development. Leveraging precision immunology, Novigenix is set to empower biopharma companies and transform cancer treatment paradigms, offering a breakthrough in personalized cancer treatment. With a team of over 20 Ph.D.-level scientists dedicated to advancing next-generation liquid biopsy solutions, Novigenix is at the forefront of pioneering precision immunology for superior patient outcomes. Novigenix LITOSeek AI Healthcare Solutions Precision Immunology Cancer Care
Published on 12/16/2025 at 19:25, 1 hour 5 minutes ago Cypher Metaverse Inc. Announces Signing of Definitive Agreement for Acquisition
Published on 12/16/2025 at 18:00, 2 hours 30 minutes ago RTO SPA Terminated: Mumena Mushinge, Brian Chasala, Terra Metals Inc. and Terra Metals Limited Failed to Provide Necessary Due Diligence Information and Failed to File CSE Application
Published on 12/16/2025 at 14:30, 6 hours ago Worksport Launches Rivian R1T Pickup Truck Compatible Cover, SOLIS Solar Tonneau
Published on 12/16/2025 at 14:00, 6 hours 30 minutes ago QNX Embedded Technology Now Powering More Than 275 Million Vehicles on the Road
Published on 12/16/2025 at 14:00, 6 hours 30 minutes ago Loop Industries and Ester Industries' India Joint Venture Awards Detailed Engineering Contract to Toyo for Infinite Loop(TM) India
Published on 12/16/2025 at 18:30, 2 hours ago SIX Exchange Regulation approves delisting of u-blox registered shares and grants exemption from specific disclosure requirements
Published on 12/16/2025 at 17:32, 2 hours 57 minutes ago M&G Credit Income Investment Trust plc: Net Asset Value(s)
Published on 12/16/2025 at 20:10, 19 minutes ago donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 18:53, 1 hour 36 minutes ago Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:10, 2 hours 19 minutes ago Amundi crosses the statutory threshold of 2% upwards
Published on 12/16/2025 at 17:45, 2 hours 45 minutes ago Imerys-December-2025-information-share-capital-and-voting-rights-as-of-30-November-2025
Published on 12/16/2025 at 17:43, 2 hours 47 minutes ago Aéroports de Paris S.A - November 2025 traffic figures